pancreatic adenocarcinoma (Disease)

Synonyms:pancreas adenocarcinoma

Id:DOID:4074

Description:A pancreatic carcinoma that derives_from epithelial cells of glandular origin.

Results found

Linked to

	Label	Description
	YAPC Subject (Entity type)	A subject from LINCS produced as part of the LINCS project
	YAPC.311 Subject (Entity type)	A subject from LINCS produced as part of the LINCS project
	DANG.311 Subject (Entity type)	A subject from LINCS produced as part of the LINCS project
	L1000 LINCS DCIC REP.A014 YAPC 24H H15 ubenimex 1.11um Biosample (Entity type)	A biosample from LINCS produced as part of the L1000 Phase2 project
	L1000 LINCS DCIC REP.A006 YAPC 24H P15 warfarin 1.11um Biosample (Entity type)	A biosample from LINCS produced as part of the L1000 Phase2 project
	L1000 LINCS DCIC 2021 LJP007 YAPC 24H C13 SAR-245409 10uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC 2021 XPR014 YAPC.311 96H G24 CDKAL1 Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC 2021 REP.A013 YAPC 24H E23 epirizole 0.125uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC REP.A028 YAPC 24H M10 itopride 0.37um Biosample (Entity type)	A biosample from LINCS produced as part of the L1000 Phase2 project
	L1000 LINCS DCIC REP.A003 YAPC 24H F24 azathioprine 0.04um Biosample (Entity type)	A biosample from LINCS produced as part of the L1000 Phase2 project

YAPC

Subject (Entity type)

A subject from LINCS produced as part of the LINCS project

YAPC.311

Subject (Entity type)

A subject from LINCS produced as part of the LINCS project

DANG.311

Subject (Entity type)

A subject from LINCS produced as part of the LINCS project

L1000 LINCS DCIC REP.A014 YAPC 24H H15 ubenimex 1.11um

Biosample (Entity type)

A biosample from LINCS produced as part of the L1000 Phase2 project

L1000 LINCS DCIC REP.A006 YAPC 24H P15 warfarin 1.11um

Biosample (Entity type)

A biosample from LINCS produced as part of the L1000 Phase2 project

L1000 LINCS DCIC 2021 LJP007 YAPC 24H C13 SAR-245409 10uM

Biosample (Entity type)

A biosample from LINCS produced as part of the LINCS 2021 project

L1000 LINCS DCIC 2021 XPR014 YAPC.311 96H G24 CDKAL1

Biosample (Entity type)

A biosample from LINCS produced as part of the LINCS 2021 project

L1000 LINCS DCIC 2021 REP.A013 YAPC 24H E23 epirizole 0.125uM

Biosample (Entity type)

A biosample from LINCS produced as part of the LINCS 2021 project

L1000 LINCS DCIC REP.A028 YAPC 24H M10 itopride 0.37um

Biosample (Entity type)

A biosample from LINCS produced as part of the L1000 Phase2 project

L1000 LINCS DCIC REP.A003 YAPC 24H F24 azathioprine 0.04um

Biosample (Entity type)

A biosample from LINCS produced as part of the L1000 Phase2 project

DISPLAY PER PAGE

CFDE Workbench

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

CFDE Workbench

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025

This repository is under review for potential modification in compliance with Administration directives.